Evidence map›Paper›PMID 39722036›Full record

ArticleBiology direct2024

Exploring the molecular mechanism of estrogen therapy effectiveness after TCRA in IUA patients at single-cell level.

Yue Du, Ruzhen Shuai, Sang Luo, Yiran Jin, Fengjuan Xu, Jingyi Zhang, Dan Liu, Limin Feng

Abstract read
In one paragraph

Article in Biology direct, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yue DuDepartment of Obstetrics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China.
Ruzhen ShuaiDepartment of Obstetrics and Gynecology, Gansu Provincial Hospital, Lanzhou, Gansu, 730000, China.
Sang LuoDepartment of Beijing National Biochip Research Center Sub-Center in Ningxia, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China.
Yiran JinDepartment of Beijing National Biochip Research Center Sub-Center in Ningxia, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China.
Fengjuan XuThe First School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, 750004, China.
Jingyi ZhangThe First School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, 750004, China.
Dan LiuDepartment of Beijing National Biochip Research Center Sub-Center in Ningxia, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China. nxld@nyfy.com.cn.
Limin FengDepartment of Obstetrics and Gynecology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China. lucyfeng1966@163.com.

Funding

Central Guiding Local Science and Technology Development Project of Ningxia No.2022YDDF0155National Natural Science Foundation of China No.82260300Ningxia Science and Technology Innovation Leading Talent Project No.2022GKLRLX010
6 · The paper itself

Abstract

backgroundIntrauterine adhesion (IUA) is a common cause of clinically refractory infertility, and there exists significant heterogeneity in the treatment outcomes among IUA patients with the similar severity after transcervical resection of adhesion(TCRA). The underlying mechanism of different treatment outcomes occur remains elusive, and the precise contribution of various cell subtypes in this process remains uncertain.

resultsHere, we performed single-cell transcriptome sequencing on 10 human endometrial samples to establish a single-cell atlas differences between patients who responded to estrogen therapy and those who did not. The results showed increased infiltration of immune cells such as monocyte macrophages, T cells, and natural killer (NK) cells in patients who did not respond to estrogen therapy. Our findings indicate that distinct fibroblast subsets are implicated in the modulation of the Wnt, Hippo, and Hedgehog signaling pathways, as evidenced by functional enrichment analyses. This may have implications for the therapeutic efficacy in patients with IUA. Furthermore, we delineated the markers and transcriptional status of different macrophage subsets and identified two cell clusters, CXCL10high and CCL4L2high macrophage subsets, which are intimately associated with inflammation and fibrosis. The state of fibrosis and inflammatory response in human endometrial tissues with disparate treatment outcomes is revealed, and providing evidence to clarify the underlying determinants of sensitivity to estrogen therapy.

conclusionsWe described the transcriptional status of different cell subtypes in the two groups of patients, providing new ideas for exploring the molecular mechanism of the difference in the effectiveness of estrogen therapy in patients, and providing theoretical basis for providing precise and individualized treatment plans for IUA patients.

Indexed as

EstrogensSingle-Cell AnalysisAdultEndometriumFemaleHumansMacrophagesSignal TransductionTissue AdhesionsTranscriptomeUterine DiseasesEstrogensEndometrial fibrosisEstrogenIntrauterine adhesionMacrophageSingle-cell RNA-seq

Identifiers

PMID39722036
PMCPMC11670502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.